Venebio Group announces Catherine Vick as new President and Chief Executive Officer.

Venebio Group, LLC is pleased to announce new leadership with the appointment of Catherine Vick as CEO.?

Ms. Vick, also known as Katie, is well poised to take the helm and install the updated vision for Venebio Group. Venebio Group provides tailored services to its clients and Katie is committed to these services and ensuring that each client continues to have a dedicated scientist as their primary point of contact. As part of the new vision, Venebio Group will continue, under her leadership, to expand offerings to meet the needs of clients and to provide greater flexibility in the provision of services.?

Katie has been with Venebio Group for over a decade. She has been instrumental in building a strong network of consultants with both extensive breadth and depth across multiple disciplines and therapeutic areas,? from epidemiology (including real world evidence, market scoping), to regulatory (submissions, postmarketing studies, REMS, harm reduction), ?to health economics (including Dossier preparation) and to specialized scientific support for litigators.? While she, herself, is a methods epidemiologist with specialized training in study design, advanced analytics, and program evaluation, importantly she and her team have credentials and networks in pharmaceutical, medical device, and consumer goods arenas.?

Katie’s leadership style emphasizes collaborative decision-making, mentorship, and open communication, which allows her to build lean, high-performing teams that foster a culture of innovation while continuing to enhance Venebio’s boutique, personalized client experience.??

Venebio’s founder, Lenn Murrelle states, “Naming Katie as CEO of Venebio Group marks an exciting new chapter. Katie brings an impressive blend of leadership, scientific expertise, and vision which will guide Venebio on a path for sustainable and impactful growth. Over the past 12 years, I have seen that Katie is dedicated to driving excellence, fostering innovation, and delivering meaningful results for our clients and partners. Please join me in congratulating Katie on her new role, and welcoming her as she leads Venebio forward, helping our clients navigate their most complex challenges with expertise and care.”